The top three pharmacy benefit managers hiked the prices of dozens of “specialty” generic drugs, some by more than 1,000% of their acquisition cost, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.